The "Remote Patient Monitoring Systems - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Amid the COVID-19 crisis and the looming economic recession, the Remote Patient Monitoring Systems market worldwide will grow by a projected US$1 Billion, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 12.9%. The global analysis and forecast periods covered are 2020-2027 (current & future analysis) and 2012-2019 (historic review). Research estimates are provided for 2020, while research projections cover the period 2021-2027.
Vital Sign Monitors, one of the segments analyzed and sized in this study, is forecast to grow at over 14.7% and reach a market size of US$524.5 Million by the end of the analysis period. An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry. The Vital Sign Monitors market will be reset to a new normal which going forward in a post COVID-19 era will be continuously redefined and redesigned. Staying on top of trends and accurate analysis is paramount now more than ever to manage uncertainty, change and continuously adapt to new and evolving market conditions.
As part of the new emerging geographic scenario, the United States is forecast to readjust to a 14.3% CAGR. Within Europe, the region worst hit by the pandemic, Germany will add over US$36.3 Million to the region's size over the next 7 to 8 years. In addition, over US$45.5 Million worth of projected demand in the region will come from Rest of the European markets. In Japan, the Vital Sign Monitors segment will reach a market size of US$38.4 Million by the close of the analysis period.
Blamed for the pandemic, significant political and economic challenges confront China. Amid the growing push for decoupling and economic distancing, the changing relationship between China and the rest of the world will influence competition and opportunities in the Remote Patient Monitoring Systems market. Against this backdrop and the changing geopolitical, business and consumer sentiments, the world's second largest economy will grow at 13.1% over the next couple of years and add approximately US$141.6 Million in terms of addressable market opportunity.
Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing Remote Patient Monitoring Systems market landscape. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.
Competitors identified in this market include, among others:
- Biotronik SE & Co. KG
- F. Hoffmann-La Roche AG
- Intel Corporation
- Johnson & Johnson
- Koninklijke Philips N.V.
- Medtronic of Canada Ltd.
- Philips Healthcare
- Robert Bosch GmbH
- Welch Allyn Inc.
Key Topics Covered
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Global Competitor Market Shares
- Remote Patient Monitoring Systems Competitor Market Share Scenario Worldwide (in %): 2019 & 2028
- Impact of COVID-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
- Total Companies Profiled: 83
For more information about this report visit https://www.researchandmarkets.com/r/nrjann.
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900